| Dr Heidi Rebekah Kemmer, DO | |
|
2750 Clay Edwards Dr Ste 600, North Kansas City, MO 64116-3258 | |
| (816) 453-4000 | |
| (816) 842-1486 |
| Full Name | Dr Heidi Rebekah Kemmer |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 13 Years |
| Location | 2750 Clay Edwards Dr Ste 600, North Kansas City, Missouri |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427344266 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Overland Park Reg Med Ctr | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meritas Health Corporation | 6305748153 | 365 |
News Archive
In a Vancouver Sun opinion piece, columnist Barbara Yaffe writes about the "disappointing track record of delivery on past G8 aid promises" in light of recent concern over Canada's announcement that it will not fund abortion in its G8 initiative.
The National Association For Continence awarded Gamal Ghoniem, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics and Female Urology Awards Reception on March 4, held during the 2011 SUFU Winter Meeting in Phoenix, AZ.
Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson's disease. The finding is promising for the development of a method enabling early identification of the disease.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 2 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
In a Vancouver Sun opinion piece, columnist Barbara Yaffe writes about the "disappointing track record of delivery on past G8 aid promises" in light of recent concern over Canada's announcement that it will not fund abortion in its G8 initiative.
The National Association For Continence awarded Gamal Ghoniem, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics and Female Urology Awards Reception on March 4, held during the 2011 SUFU Winter Meeting in Phoenix, AZ.
Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson's disease. The finding is promising for the development of a method enabling early identification of the disease.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 2 days ago
| Entity Name | Glenarm Acute Surgical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760934889 PECOS PAC ID: 5698050532 Enrollment ID: O20170316000956 |
News Archive
In a Vancouver Sun opinion piece, columnist Barbara Yaffe writes about the "disappointing track record of delivery on past G8 aid promises" in light of recent concern over Canada's announcement that it will not fund abortion in its G8 initiative.
The National Association For Continence awarded Gamal Ghoniem, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics and Female Urology Awards Reception on March 4, held during the 2011 SUFU Winter Meeting in Phoenix, AZ.
Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson's disease. The finding is promising for the development of a method enabling early identification of the disease.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heidi Rebekah Kemmer, DO 2750 Clay Edwards Dr Ste 600, North Kansas City, MO 64116-3258 Ph: (816) 453-4000 | Dr Heidi Rebekah Kemmer, DO 2750 Clay Edwards Dr Ste 600, North Kansas City, MO 64116-3258 Ph: (816) 453-4000 |
News Archive
In a Vancouver Sun opinion piece, columnist Barbara Yaffe writes about the "disappointing track record of delivery on past G8 aid promises" in light of recent concern over Canada's announcement that it will not fund abortion in its G8 initiative.
The National Association For Continence awarded Gamal Ghoniem, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics and Female Urology Awards Reception on March 4, held during the 2011 SUFU Winter Meeting in Phoenix, AZ.
Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson's disease. The finding is promising for the development of a method enabling early identification of the disease.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 2 days ago
Dr. Kyle Harken, D.O. Surgery Medicare: May Accept Medicare Assignments Practice Location: 2750 Clay Edwards Dr Ste 600, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1486 | |
Dr. Jon S Gengler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1425 | |
Dr. Frank Scott Werner, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1425 | |
Joshua Michael Mourot, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 600, North Kansas City, MO 64116 Phone: 816-691-5048 Fax: 816-346-7039 | |
Dr. Jun Ungos Elegino, DO Surgery Medicare: Medicare Enrolled Practice Location: 2750 Clay Edwards Dr Ste 312, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1486 | |
Dr. Austin J Wagner, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 304, North Kansas City, MO 64116 Phone: 816-842-5555 Fax: 816-842-8888 | |
Dr. Scott W Kujath, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 304, North Kansas City, MO 64116 Phone: 816-842-5555 Fax: 816-842-8888 |